Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice

Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1112-H1126. doi: 10.1152/ajpheart.00089.2018. Epub 2018 Jul 13.

Abstract

The objective of the present study was to 1) analyze the ascending aortic proteome within a mouse model of Marfan syndrome (MFS; Fbn1C1041G/+) at early and late stages of aneurysm and 2) subsequently test a novel hypothesis formulated on the basis of this unbiased proteomic screen that links changes in integrin composition to transforming growth factor (TGF)-β-dependent activation of the rapamycin-independent component of mammalian target of rapamycin (Rictor) signaling pathway. Ingenuity Pathway Analysis of over 1,000 proteins quantified from the in vivo MFS mouse aorta by data-independent acquisition mass spectrometry revealed a predicted upstream regulator, Rictor, that was selectively activated in aged MFS mice. We validated this pattern of Rictor activation in vivo by Western blot analysis for phosphorylation on Thr1135 in a separate cohort of mice and showed in vitro that TGF-β activates Rictor in an integrin-linked kinase-dependent manner in cultured aortic vascular smooth muscle cells. Expression of β3-integrin was upregulated in the aged MFS aorta relative to young MFS mice and wild-type mice. We showed that β3-integrin expression and activation modulated TGF-β-induced Rictor phosphorylation in vitro, and this signaling effect was associated with an altered vascular smooth muscle cell proliferative-migratory and metabolic in vitro phenotype that parallels the in vivo aneurysm phenotype in MFS. These results reveal that Rictor is a novel, context-dependent, noncanonical TGF-β signaling effector with potential pathogenic implications in aortic aneurysm. NEW & NOTEWORTHY We present the most comprehensive quantitative analysis of the ascending aortic aneurysm proteome in Marfan syndrome to date resulting in novel and potentially wide-reaching findings that expression and signaling by β3-integrin constitute a modulator of transforming growth factor-β-induced rapamycin-independent component of mammalian target of rapamycin (Rictor) signaling and physiology in aortic vascular smooth muscle cells.

Keywords: Marfan syndrome; Rictor; aortic aneurysm; data-independent acquisition mass spectrometry; integrin signaling; transforming growth factor-β.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Aorta / metabolism
  • Aorta / pathology
  • Aortic Aneurysm / etiology
  • Aortic Aneurysm / metabolism*
  • Aortic Aneurysm / pathology
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Chromatography, High Pressure Liquid
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Disease Progression
  • Fibrillin-1 / genetics
  • Genetic Predisposition to Disease
  • Integrin beta3 / metabolism
  • Male
  • Marfan Syndrome / complications*
  • Marfan Syndrome / genetics
  • Mass Spectrometry
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscle, Smooth, Vascular / metabolism*
  • Muscle, Smooth, Vascular / pathology
  • Mutation
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / pathology
  • Phenotype
  • Phosphorylation
  • Protein Serine-Threonine Kinases / metabolism
  • Proteomics / methods*
  • Rapamycin-Insensitive Companion of mTOR Protein / metabolism*
  • Signal Transduction
  • Time Factors
  • Transforming Growth Factor beta / metabolism*

Substances

  • Fibrillin-1
  • Integrin beta3
  • Rapamycin-Insensitive Companion of mTOR Protein
  • Transforming Growth Factor beta
  • rictor protein, mouse
  • integrin-linked kinase
  • Protein Serine-Threonine Kinases